<DOC>
	<DOCNO>NCT02541786</DOCNO>
	<brief_summary>Dexlansoprazole MR R-enantiomer lansoprazole deliver dual delayed release formulation . It effective symptom control patient gastroesophageal reflux disease . However , efficacy treatment H.pylori infection remain unclear . This study conduct investigate whether efficacy single-dose dexlansoprazole MR-based triple therapy non-inferior double-dose rabeprazole-based triple therapy treatment H.pylori infection .</brief_summary>
	<brief_title>Comparison Dexlansoprazole-based Triple Rabeprazole-based Triple Therapies Helicobacter Pylori Infection</brief_title>
	<detailed_description>Helicobacter pylorus ( H.pylori ) infect 50 % human globally . It major cause chronic gastritis , gastric ulcer , duodenal ulcer , gastric adenocarcinoma gastric mucosa-associated lymphoid tissue lymphoma ( MALToma ) . H.pylori eradication become standard widely adopt therapy cure peptic ulcer disease . This therapy also strongly recommend treatment H pylori-related MALToma . In region high incidence gastric adenocarcinoma , eradication H pylorus advocate preventative measure . Proton pump inhibitor ( PPI ) one key medicine anti-H pylorus regimen . It possess anti-H pylorus activity , , reduce gastric acid secretion , also increase bioavailability activity antibiotic . This study conduct investigate whether efficacy single-dose dexlansoprazole MR-based triple therapy non-inferior double-dose rabeprazole-based triple therapy treatment H pylori infection .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>1 . Male nonpregnant female age 20 year . 2 . H. pyloriinfected outpatient 3 . Mental legal ability give write informed consent . 1. previous H pylorieradication therapy , 2. ingestion antibiotic bismuth within prior 4 week , 3. patient allergic history medication use , 4. patient previous gastric surgery , 5. coexistence serious concomitant illness ( example , decompensated liver cirrhosis , uremia ) , 6. pregnant woman .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>dexlansoprazole MR</keyword>
	<keyword>rabeprazole</keyword>
	<keyword>Helicobacter pylorus</keyword>
	<keyword>triple therapy</keyword>
</DOC>